Afya Enterprise Value Over E B I T D A from 2010 to 2024

AFYA Stock  USD 16.26  0.10  0.61%   
Afya's Enterprise Value Over EBITDA is decreasing over the years with slightly volatile fluctuation. Enterprise Value Over EBITDA is expected to dwindle to 10.81. From 2010 to 2024 Afya Enterprise Value Over EBITDA quarterly data regression line had arithmetic mean of  83.02 and r-squared of  0.82. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
11.38159213
Current Value
10.81
Quarterly Volatility
56.75142177
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Afya financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Afya's main balance sheet or income statement drivers, such as Tax Provision of 24.8 M, Interest Income of 25.3 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 3.18, Dividend Yield of 0.0037 or PTB Ratio of 2.54. Afya financial statements analysis is a perfect complement when working with Afya Valuation or Volatility modules.
  
Check out the analysis of Afya Correlation against competitors.
For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.

Latest Afya's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Afya over the last few years. It is Afya's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Afya's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Afya Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean83.02
Geometric Mean55.42
Coefficient Of Variation68.36
Mean Deviation52.51
Median132.24
Standard Deviation56.75
Sample Variance3,221
Range122
R-Value(0.90)
Mean Square Error634.14
R-Squared0.82
Slope(11.47)
Total Sum of Squares45,090

Afya Enterprise Value Over E B I T D A History

2024 10.81
2023 11.38
2022 10.57
2021 17.68
2020 28.34
2019 29.8
2018 78.7

About Afya Financial Statements

Afya stakeholders use historical fundamental indicators, such as Afya's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Afya investors may analyze each financial statement separately, they are all interrelated. For example, changes in Afya's assets and liabilities are reflected in the revenues and expenses on Afya's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Afya. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 11.38  10.81 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Afya offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Afya's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Afya Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Afya Stock:
Check out the analysis of Afya Correlation against competitors.
For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Diversified Consumer Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Afya. If investors know Afya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Afya listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.891
Earnings Share
1.1
Revenue Per Share
34.119
Quarterly Revenue Growth
0.137
Return On Assets
0.0711
The market value of Afya is measured differently than its book value, which is the value of Afya that is recorded on the company's balance sheet. Investors also form their own opinion of Afya's value that differs from its market value or its book value, called intrinsic value, which is Afya's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Afya's market value can be influenced by many factors that don't directly affect Afya's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Afya's value and its price as these two are different measures arrived at by different means. Investors typically determine if Afya is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Afya's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.